Published in J Nat Prod on October 12, 2011
cis-trans Isomerization of silybins A and B. Beilstein J Org Chem (2014) 0.76
Chalcone Isomerase from Eubacterium ramulus Catalyzes the Ring Contraction of Flavanonols. J Bacteriol (2016) 0.75
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature (2013) 3.60
Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis (2014) 2.59
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation (2006) 2.41
Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr (2010) 2.17
Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res (2003) 2.07
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05
Inflammasomes: current understanding and open questions. Cell Mol Life Sci (2010) 1.87
Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol (2003) 1.77
Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism. Endocrinology (2011) 1.51
Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One (2013) 1.30
CCR2 mediates homeostatic and inflammatory release of Gr1(high) monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. J Immunol (2008) 1.28
Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr (2003) 1.26
Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice. Clin Cancer Res (2004) 1.25
Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol (2002) 1.22
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood (2011) 1.19
Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst Appl Microbiol (2002) 1.17
Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr (2007) 1.16
Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res (2008) 1.14
Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol (2006) 1.13
Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology (2005) 1.11
Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol (2009) 1.11
Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst Appl Microbiol (2007) 1.10
Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr (2011) 1.09
Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes (2012) 1.08
Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues. Cancer Res (2003) 1.07
Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol (2005) 1.06
Modulation of gut mucosal biofilms. Br J Nutr (2005) 1.03
Long-term stability of the human gut microbiota in two different rat strains. Curr Issues Mol Biol (2008) 1.02
The Toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ Microbiol (2007) 1.01
Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition. J Med Chem (2005) 1.01
Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes (2011) 1.00
Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int J Syst Evol Microbiol (2013) 1.00
Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe (2005) 0.99
Development of nitrile-based peptidic inhibitors of cysteine cathepsins. Curr Top Med Chem (2010) 0.99
Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface. Biochem J (2010) 0.99
Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One (2009) 0.99
Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol (2009) 0.97
Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res (2009) 0.97
Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett (2002) 0.96
Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol (2012) 0.96
Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.95
Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis (2011) 0.94
Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol (2003) 0.94
Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr (2005) 0.94
Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol (2009) 0.93
Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors. J Med Chem (2004) 0.93
Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol (2008) 0.92
A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer. Nat Chem Biol (2012) 0.92
Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl Environ Microbiol (2010) 0.92
Interaction of papain-like cysteine proteases with dipeptide-derived nitriles. J Med Chem (2005) 0.92
Identification of the first low-molecular-weight inhibitors of matriptase-2. J Med Chem (2010) 0.90
Quantitative analysis of type I collagen fibril regulation by lumican and decorin using AFM. J Struct Biol (2013) 0.90
Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol Ecol (2006) 0.90
Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice. Environ Microbiol (2008) 0.90
Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos (2009) 0.89
The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions. J Biol Chem (2014) 0.89
The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice. J Nutr Biochem (2008) 0.89
Recent developments and perspectives in the investigation of probiotic effects. Int J Med Microbiol (2009) 0.89
Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microbiol (2013) 0.88
The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr (2009) 0.88
Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinant enzyme. Appl Environ Microbiol (2004) 0.88
Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr (2011) 0.88
Structural optimization of azadipeptide nitriles strongly increases association rates and allows the development of selective cathepsin inhibitors. J Med Chem (2010) 0.87
Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: identification of a hypoxia-responsive element in the TMPRSS6 promoter region. Biol Chem (2012) 0.86
Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2. Biochem J (2013) 0.86
Bioavailability of lignans in human subjects. Nutr Res Rev (2006) 0.86
Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria. PLoS One (2013) 0.86
Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res (2003) 0.86
Mutagenicity of arbutin in mammalian cells after activation by human intestinal bacteria. Food Chem Toxicol (2006) 0.86
Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes (2011) 0.85
Cytotoxic and HLE-inhibitory tetramic acid derivatives from marine-derived fungi. Nat Prod Commun (2009) 0.85
Cleavage of four carbon-carbon bonds during biosynthesis of the griseorhodin a spiroketal pharmacophore. J Am Chem Soc (2009) 0.85
Compatible solutes as protectants for zymogens against proteolysis. Biochim Biophys Acta (2006) 0.84
Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets. ChemMedChem (2008) 0.84
Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab (Lond) (2011) 0.84
Systematic identification and classification of three-dimensional activity cliffs. J Chem Inf Model (2012) 0.83
Facing the gem-dialkyl effect in enzyme inhibitor design: preparation of homocycloleucine-based azadipeptide nitriles. Chemistry (2011) 0.83
A coumarin-labeled vinyl sulfone as tripeptidomimetic activity-based probe for cysteine cathepsins. Chembiochem (2014) 0.83
Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG. ACS Chem Biol (2013) 0.83
Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. Environ Microbiol (2010) 0.83
New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase. Chembiochem (2008) 0.83
Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol Nutr Food Res (2010) 0.82
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity. Bioorg Med Chem Lett (2009) 0.82
Synthesis and radiopharmacological characterisation of a fluorine-18-labelled azadipeptide nitrile as a potential PET tracer for in vivo imaging of cysteine cathepsins. ChemMedChem (2013) 0.82
Cyplecksins are covalent inhibitors of the pleckstrin homology domain of cytohesin. Angew Chem Int Ed Engl (2013) 0.81
Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol (2010) 0.81
Inhibition of human leukocyte elastase by brunsvicamides a-C: cyanobacterial cyclic peptides. ChemMedChem (2009) 0.80